MICHELLE DEVOLL: Open Payments
NPI 1023520327 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 122 payments from 26 companies in 2025. Trend: 2023 $1,850 · 2024 $2,007 · 2025 $2,023
Food & beverage: $2,023
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $301 |
| ABBVIE INC. | 25 | $294 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $276 |
| Amgen Inc. | 12 | $155 |
| Phathom Pharmaceuticals, Inc. | 5 | $102 |
| Lundbeck LLC | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $89 |
| Astellas Pharma US Inc | 5 | $87 |
| PFIZER INC. | 4 | $68 |
| Alexion Pharmaceuticals, Inc. | 3 | $54 |
Products named: CAPLYTA, AIRSUPRA, FARXIGA, REXULTI, VRAYLAR, VOQUEZNA, Kerendia, UBRELVY.
Industry payments across OH — which companies pay providers there.
